Roche: 'Largest biomanufacturing capacity across the industry' to get bigger
Roche says it will continue to expand its biologics manufacturing capacity while reducing its small molecule network.
Roche says it will continue to expand its biologics manufacturing capacity while reducing its small molecule network.
The Charles Stark Draper Lab has developed two microfluidic prototypes to help make the manufacturing of cell therapies cheaper and more efficient.